Formulierungen mit Amiodaron und Sulfoalkylether-Cyclodextrin

Patent europeic · EP2402008 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2402008
Numer da la dumonda
EP11182697
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-04-2003
Publitgà
04-01-2012
Concedì
27-01-2016
Stritgà
30-04-2023
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 31/343 (2006.01)
A61K 47/48 (2006.01)
Prioritad
US 139620 04.05.2002
Derivà da
EP03728598
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-04-2023

    Durada maximala cuntanschida

    Published in Swissreg on 30.04.2023

  2. 12-04-2016

    Represchentant inscrit

    Representative
    Troesch Scheidegger Werner AG, Schwäntenmos 14, 8126 Zumikon

    Published in Swissreg on 12.04.2016

  3. 27-01-2016

    Concedì

    Published in Swissreg on 27.01.2016

Partidas

Possessur

CYDEX PHARMACEUTICALS, INC.

CyDex Pharmaceuticals, Inc.

11119 North Torrey Pines Road, Suite 200, La Jolla, CA 92037, US

Represchentant

Troesch Scheidegger Werner AG

Schwäntenmos 14, 8126 Zumikon

Inventur

Mosher, Gerold, L.

Kansas City, MO Missouri 64145, US

Johnson, Karen T.

Lawrence, KS 66047-1729, US

Gayed, Atef A.

Overland Park, KS Kansas 66209, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.